Related Experiment Video
Updated: Nov 14, 2025
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Sirtuin 1 activated by SRT1460 protects against myocardial ischemia/reperfusion injury
Shanjun Zhao1, Lei Yu2,3
1Department of Ward 1 of Cardiovascular Medicine, Panyu Central Hospital, Guangzhou, China.
Background:
Ischemia reperfusion usually results in certain degree of damage to the myocardium, which is called myocardial ischemia/reperfusion (I/R) injury.
Objective:
Previous studies have found that Sirt1 plays a critical role in I/R injury by protecting cardiac function. SRT1460 is the activator for Sirt1 that participates in the regulation of various diseases. However, whether SRT1460 has any effects on myocardial I/R injury needs further study.
Methods:
The I/R rat model and H/R H9C2 model were established to simulate myocardial I/R injury. The infarct area of the rat heart was examined through TTC staining. The EF and FS of rats were detected through echocardiography. The levels of CK-MB, LDH, MDA, SOD and CK in cardiac tissues, serum or H9C2 cells were measured using commercial kits. Cell viability was assessed through MTT assay. Apoptosis was determined through flow cytometry analysis. Sirt1 expression was measured through western blot.
Results:
Our work found that SRT1460 reduced the infarct area of the heart induced by myocardial I/R injury. In addition, SRT1460 was confirmed to ameliorate cardiac dysfunction induced by myocardial I/R injury. Further exploration discovered that SRT1460 weakened oxidative stress induced by myocardial I/R injury. Findings from in vitro assays demonstrated that SRT1460 relieved injury of H/R-treated H9C2 cells. Finally, rescue assays proved that Sirt1 knockdown reversed the protective effects of SRT1460 on the injury of H/R-treated H9C2 cells.
Conclusion:
Sirt1 activated by SRT1460 protected against myocardial I/R injury. This discovery may offer new sights on the treatment of myocardial I/R injury.
Insights
SRT1460, an activator of Sirt1, significantly reduces heart damage and improves cardiac function following myocardial ischemia/reperfusion (I/R) injury. This study demonstrates SRT1460
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Cellular Biology
Background:
- Myocardial ischemia/reperfusion (I/R) injury causes significant damage to the heart.
- Sirtuin 1 (Sirt1) is known to protect cardiac function during I/R injury.
- SRT1460 is a Sirt1 activator with potential therapeutic applications.
Purpose of the Study:
- To investigate the protective effects of SRT1460 on myocardial I/R injury.
- To explore the underlying mechanisms involving Sirt1 activation.
- To evaluate SRT1460's efficacy in both in vivo and in vitro models.
Main Methods:
- Established rat and H9C2 cell models of myocardial I/R injury.
- Assessed infarct size, cardiac function (EF, FS), and cardiac biomarkers (CK-MB, LDH).
- Measured oxidative stress markers (MDA, SOD), cell viability (MTT), apoptosis, and Sirt1 expression (Western blot).
Main Results:
- SRT1460 significantly reduced infarct area and improved cardiac function in I/R rats.
- SRT1460 alleviated oxidative stress and protected H9C2 cells from hypoxia/reoxygenation injury.
- Sirt1 knockdown reversed the protective effects of SRT1460, confirming Sirt1's crucial role.
Conclusions:
- Sirt1 activation by SRT1460 provides significant protection against myocardial I/R injury.
- SRT1460 demonstrates therapeutic potential for treating myocardial I/R injury.
- Targeting Sirt1 with SRT1460 offers a promising strategy for cardiovascular protection.
